FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and represents a pharmaceutical composition used in treating new growths and containing: artemisinin, artemether, arteether, artenimol or artesunate and a pharmaceutically acceptable excipient specified in a group consisting of: medium-chain triglycerides, short-chain triglycerides; omega-3-marine triglycerides; and cod liver oil high in omega-3-fatty acids wherein the above composition is presented in the form of a preparation for transmucosal, sublingual, buccal or nasal dosage.
EFFECT: provided high bioavailability and stability; prevented self-induction.
15 cl, 11 tbl, 14 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| NEW COMPOSITIONS AND METHODS | 2018 |
|
RU2767410C2 |
| COMPOSITIONS CONTAINING TRIPTANE COMPOUNDS | 2010 |
|
RU2710372C2 |
| TREATING OR PREVENTING SEBORRHEIC KERATOSIS USING ARTEMISININ AND DERIVATIVES THEREOF | 2015 |
|
RU2702347C2 |
| COMPOSITIONS CONTAINING TRIPTANE COMPOUNDS | 2019 |
|
RU2762725C2 |
| COMBINATION OF QUINOLINE-4-CARBOXAMIDES AND BENZONAPHTHYRIDINE DERIVATIVES AS A COMBINED ANTIMALARIA MEDICINE | 2019 |
|
RU2806303C2 |
| COVALENT CONJUGANTS BETWEEN ENDOPEROXIDES RELATED TO ARTEMIZININ AND FERRIFEROUS PROTEINS AND METHODS OF APPLICATION | 2003 |
|
RU2325156C2 |
| TABLET OF MELATONIN AND METHOD FOR PREPARING AND USING | 2008 |
|
RU2485949C2 |
| METHOD OF TREATING MALARIA USING A THERAPEUTIC COMBINATION OF TELOMERASE INHIBITORS (IIMATINIB MESILATE) AND ARTEMETHER | 2019 |
|
RU2722981C1 |
| GALENIC FORM FOR TRANSMUCOSAL-BUCCAL ADMINISTRATION OF TRIPTANES | 2009 |
|
RU2492852C2 |
| TRANSMUCOSAL SYSTEM OF DELIVERY OF MEDICAL PRODUCTS | 2004 |
|
RU2342953C2 |
